Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

<< Previous

Bullboard Posts

Next >>

Post by Red~Oneon Nov 07, 2022 10:59am

187 Views

Post# 35078911

Clas.....CLas......CLAS!!!

Well if you want to get into the Blame Game.......

1) Never Fall in Love With a Stock

2) Never over extend yourself and make foolish decisions , usually because you broke Rule # 1

3) If you are unsure then buy or sell in thirds or halves

4) If you start believing the Pump when you know in your heart something is wrong, then maybe Penny Stocks are not for you

5) Be prepared to lose....have a plan in mind if things start to go bad and don't be afraid to lose some money to get out

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments